Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 4,321–4,340 of 17,937 drug recalls

Drug Recall Terminated Historical recordClass II

Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03

by Aurobindo Pharma USA Inc.

Reason
Failed Impurities/Degradation Specifications
Recall initiated
January 14, 2022
Reported by FDA
February 23, 2022
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

NaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx- Joint Cream, 4 oz tubes, Manufactured for NaturesPlus 548 Broadhollow Road, Melville, NY 11747, USA

by Organics Corporation of America DBA Ambix Laboratories

Reason
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCT: microbial contaminant identified as Pluralibacter gergoviae.
Recall initiated
December 6, 2021
Reported by FDA
February 23, 2022
Distribution
The product went to one consignee. Natural Organics, Inc., 548 Broadhollow Rd., Melville, NY 11747.

View recall →

Drug Recall Terminated Historical recordClass II

Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and DROPPER, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1768-36.

by Lannett Company, Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specification results for related substances.
Recall initiated
February 9, 2022
Reported by FDA
February 23, 2022
Distribution
Product was distributed nationwide in the USA.

View recall →

Drug Recall Terminated Historical recordClass I

365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONAL

by Je Dois Lavoir LLC

Reason
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.
Recall initiated
August 2, 2021
Reported by FDA
February 23, 2022
Distribution
Sold online via website nationwide in the USA and Canada.

View recall →

Drug Recall Terminated Historical recordClass I

HARD DAWN, Rise and Shine capsules, 500 mg, packaged in 10-count blisters per carton, Made in Malaysia, UPC 680044 364926, ASIN: B077XCCL59

by Esupplementsales, LLC

Reason
Marketed Without an Approved NDA/ANDA: Firm was informed by Amazon that analytical testing showed the presence of tadalafil. Tadalafil is a FDA approved drug, making this product an unapproved drug.
Recall initiated
January 28, 2022
Reported by FDA
February 16, 2022
Distribution
Nationwide in the USA via Amazon at www.amazon.com

View recall →

Drug Recall Terminated Historical recordClass I

MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, ASIN B08Z74KS88

by Junp Hydration LLC

Reason
Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Recall initiated
February 4, 2022
Reported by FDA
February 16, 2022
Distribution
Product was distributed nationwide in the USA via Amazon Marketplace

View recall →

Drug Recall Terminated Historical recordClass I

Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, Distributed by: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-234-10

by AuroMedics Pharma LLC

Reason
Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Nationwide in the US

View recall →

Drug Recall Terminated Historical recordClass II

Cystex Tablet (Sodium Salicylate 162.5 mg, Methenamine 162 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY 62959-945-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Drug Recall Terminated Historical recordClass II

DBI Magnums Tablet (Caffeine 200 mg) 100 and 500 count & 3 and 36 count packets & Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-941-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Drug Recall Terminated Historical recordClass II

Coated Back Relief Tablet (Acetaminophen 250 mg, Magnesium Salicylate 290 mg, Caffeine 50 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-800-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Drug Recall Terminated Historical recordClass II

Legatrin (Acetaminophen 500 mg, Diphenhydramine HCl 50 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-785-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Drug Recall Terminated Historical recordClass II

Back Relief II (Acetaminophen 200 mg, Magnesium Salicylate 200 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-740-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Drug Recall Terminated Historical recordClass II

Pain Aid PMF Caplet (Acetaminophen 500 mg, Pamabrom 25 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-710-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Drug Recall Terminated Historical recordClass II

Normed Fem Tablet (Acetaminophen 325 mg, Pamabrom 25 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-701-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Drug Recall Terminated Historical recordClass II

APAP 325 mg (Acetaminophen 325 mg, Pamabrom 25 mg tablet) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-700-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Drug Recall Terminated Historical recordClass II

Migrenol Caplet (Acetaminophen 500 mg, Caffeine 65 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-565-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Drug Recall Terminated Historical recordClass II

Coated Phenylephrine HCl 5mg Tablet (Phenylephrine HCl 5mg ) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-338-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Drug Recall Terminated Historical recordClass II

Phenylephrine HCl 5 mg Tablet (Phenylephrine HCl 5mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-333-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Drug Recall Terminated Historical recordClass II

Ephedrine 25 Guaifenesin 200 Tablet (Ephedrine HCl 25 mg, Guaifenesin 200 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-320-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Drug Recall Terminated Historical recordClass II

Nutralox Peppermint Antacid (Calcium Carbonate 420 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-312-00

by ULTRAtab Laboratories, Inc.

Reason
CGMP Deviations
Recall initiated
January 26, 2022
Reported by FDA
February 16, 2022
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.